newsfilter
← Latest News
Business Wire·

Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2020 and reviewed recent business progress.